E Blanco 

Oncoimmunology Research Unit, Navarrabiomed-Fundación Miguel Servet, Universidad Pública de Navarra (UPNA), Complejo Hospitalario de Navarra (CHN), Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, 31008, Spain; Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra and Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona,31008, Spain

Gene therapy with a viral vector expressing an anti-PD-1 antibody can be improved by reprogramming tumor associated myeloid populations

G Kochan 

Navarrabiomed-Fundacion Miguel Servet

Lineage and Cancer-Polarized regulatory Interactomes in Myeloid Cells Modeling Immunosuppressive Tumor-Infiltrating Subsets

D Escors 

Navarrabiomed-Fundacion Miguel Servet; IDISNA

Interference with senescence-regulating molecular pathways in human primary T cells to enhance effector activities

Á Bella 

Program of Immunology and Immunotherapy, CIMA Universidad de Navarra, Pamplona, Spain; Navarra Institute for Health Research (IdiSNA), Pamplona, Spain

Synergistic antitumour response with recombinant modified virus Ankara armed with CD40L and CD137L against peritoneal carcinomatosis

L Herrera 

Research Unit, Basque Center for Blood Transfusion and Human Tissues, Osakidetza, Galdakao, Spain; Cell Therapy, Stem Cells and Tissues Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.

Generation of CD19 CAR variants with NK cell specific motifs to determine the best choice for treating relapsed or refractory leukemias and lymphomas

C Morata-Tarifa 

Red Andaluza de diseño y traslación de Terapias Avanzadas. Fundación Progreso y Salud. 41092, Sevilla (España).

Non-clinical toxicology assays to demonstrate the safety of a cell medicinal product before first clinical use

N Silva-Pilipich 

Division of Gene Therapy and Regulation of Gene Expression, Cima Universidad de Navarra, Av. Pio XII 55, 31008, Pamplona, Spain; Instituto de Investigación Sanitaria de Navarra (IdISNA), Pamplona, Spain.

Intratumoral electroporation of a self-amplifying RNA expressing interleukin-12 induces antitumor effects in mouse models of cancer

M C Arufe

UDC; CICA; INIBIC

Study of ferroptosis transmission by small extracellular vesicles in epithelial ovarian cancer cells

K B Benabdellah 

Fundacion Publica Andaluza Progreso y Salud/Genyo

Fueling Cancer Immunotherapy with Genome editing

A González-Murillo 

Advanced Therapies Unit. Fundación para la Investigación Biomédica, Hospital Universitario Niño Jesús

Effective generation of tumor-infiltrating lymphocyte products from naïve and treated solid pediatric tumors using three-signal-based method

M Fernández-García 

Division of Hematopoietic Innovative Therapies, Biomedical Innovation Unit, Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT), Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) and Instituto de Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD, UAM), Madrid 28040. Spain.

Mesenchymal stromal cells stably expressing CXCR4 and IL10 reduce Th1/Th17 differentiation and induce regulatory cells production preventing GvHD development

M Palacios

CIEMAT/CIBERER; IIS-Fundación Jimenez Diaz (IIS-FJD, UA

Development of a gene editing approach for the treatment of RPL5-deficient Diamond-Blackfan anemia patients